Selected research
Market Outlook & Growth Opportunities
Global Longum Market Outlook and Growth Opportunities 2026
Market perspective
The global Longum market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Longum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Longum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Longum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Longum market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Longum market include ATCC Inc, BioCare Copenhagen ApS, Biofodan A/S, BioGaia AB, Danisco A/S, Danone SA, Deerland Enzymes Inc, Hanson Ltd and Mystic Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Longum market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Longum and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Longum sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Longum market size, projected growth trends, production technologies, key applications, and end-use industries.
Longum Segment by Company
ATCC Inc
BioCare Copenhagen ApS
Biofodan A/S
BioGaia AB
Danisco A/S
Danone SA
Deerland Enzymes Inc
Hanson Ltd
Mystic Pharmaceuticals Inc
Longum Segment by Type
0.2g/Piece
0.25g/Piece
Longum Segment by Application
Medicine
Others
Longum Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Longum status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Longum market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Longum significant trends, drivers, influence factors in global and regions.
6. To analyze Longum competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Longum market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Longum and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Longum.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Longum market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Longum industry.
Chapter 3: Detailed analysis of Longum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Longum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Longum in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.2g/Piece
- 0.25g/Piece
Applications
- Medicine
- Others
Companies covered
- ATCC Inc
- BioCare Copenhagen ApS
- Biofodan A/S
- BioGaia AB
- Danisco A/S
- Danone SA
- Deerland Enzymes Inc
- Hanson Ltd
- Mystic Pharmaceuticals Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Longum Sales Value (2021-2032)
- 1.2.2 Global Longum Sales Volume (2021-2032)
- 1.2.3 Global Longum Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Longum Market Dynamics
- 2.1 Longum Industry Trends
- 2.2 Longum Industry Drivers
- 2.3 Longum Industry Opportunities and Challenges
- 2.4 Longum Industry Restraints
3 Longum Market by Company
- 3.1 Global Longum Company Revenue Ranking in 2025
- 3.2 Global Longum Revenue by Company (2021-2026)
- 3.3 Global Longum Sales Volume by Company (2021-2026)
- 3.4 Global Longum Average Price by Company (2021-2026)
- 3.5 Global Longum Company Ranking (2024-2026)
- 3.6 Global Longum Company Manufacturing Base and Headquarters
- 3.7 Global Longum Company Product Type and Application
- 3.8 Global Longum Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Longum Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Longum Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Longum Market by Type
- 4.1 Longum Type Introduction
- 4.1.1 0.2g/Piece
- 4.1.2 0.25g/Piece
- 4.2 Global Longum Sales Volume by Type
- 4.2.1 Global Longum Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Longum Sales Volume by Type (2021-2032)
- 4.2.3 Global Longum Sales Volume Share by Type (2021-2032)
- 4.3 Global Longum Sales Value by Type
- 4.3.1 Global Longum Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Longum Sales Value by Type (2021-2032)
- 4.3.3 Global Longum Sales Value Share by Type (2021-2032)
5 Longum Market by Application
- 5.1 Longum Application Introduction
- 5.1.1 Medicine
- 5.1.2 Others
- 5.2 Global Longum Sales Volume by Application
- 5.2.1 Global Longum Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Longum Sales Volume by Application (2021-2032)
- 5.2.3 Global Longum Sales Volume Share by Application (2021-2032)
- 5.3 Global Longum Sales Value by Application
- 5.3.1 Global Longum Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Longum Sales Value by Application (2021-2032)
- 5.3.3 Global Longum Sales Value Share by Application (2021-2032)
6 Longum Regional Sales and Value Analysis
- 6.1 Global Longum Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Longum Sales by Region (2021-2032)
- 6.2.1 Global Longum Sales by Region: 2021-2026
- 6.2.2 Global Longum Sales by Region (2027-2032)
- 6.3 Global Longum Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Longum Sales Value by Region (2021-2032)
- 6.4.1 Global Longum Sales Value by Region: 2021-2026
- 6.4.2 Global Longum Sales Value by Region (2027-2032)
- 6.5 Global Longum Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Longum Sales Value (2021-2032)
- 6.6.2 North America Longum Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Longum Sales Value (2021-2032)
- 6.7.2 Europe Longum Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Longum Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Longum Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Longum Sales Value (2021-2032)
- 6.9.2 South America Longum Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Longum Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Longum Sales Value Share by Country, 2025 VS 2032
7 Longum Country-level Sales and Value Analysis
- 7.1 Global Longum Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Longum Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Longum Sales by Country (2021-2032)
- 7.3.1 Global Longum Sales by Country (2021-2026)
- 7.3.2 Global Longum Sales by Country (2027-2032)
- 7.4 Global Longum Sales Value by Country (2021-2032)
- 7.4.1 Global Longum Sales Value by Country (2021-2026)
- 7.4.2 Global Longum Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Longum Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Longum Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Longum Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Longum Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Longum Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Longum Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Longum Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Longum Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Longum Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Longum Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Longum Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Longum Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Longum Sales Value Growth Rate (2021-2032)
- 7.9.2 France Longum Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Longum Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Longum Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Longum Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Longum Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Longum Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Longum Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Longum Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Longum Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Longum Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Longum Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Longum Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Longum Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Longum Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Longum Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Longum Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Longum Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Longum Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Longum Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Longum Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Longum Sales Value Growth Rate (2021-2032)
- 7.16.2 China Longum Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Longum Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Longum Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Longum Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Longum Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Longum Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Longum Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Longum Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Longum Sales Value Growth Rate (2021-2032)
- 7.19.2 India Longum Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Longum Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Longum Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Longum Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Longum Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Longum Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Longum Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Longum Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Longum Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Longum Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Longum Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Longum Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Longum Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Longum Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Longum Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Longum Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Longum Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Longum Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Longum Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Longum Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Longum Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Longum Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Longum Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Longum Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Longum Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Longum Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Longum Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Longum Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Longum Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Longum Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Longum Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Longum Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Longum Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Longum Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Longum Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Longum Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Longum Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Longum Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Longum Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Longum Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Longum Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 ATCC Inc
- 8.1.1 ATCC Inc Company Information
- 8.1.2 ATCC Inc Business Overview
- 8.1.3 ATCC Inc Longum Sales, Value and Gross Margin (2021-2026)
- 8.1.4 ATCC Inc Longum Product Portfolio
- 8.1.5 ATCC Inc Recent Developments
- 8.2 BioCare Copenhagen ApS
- 8.2.1 BioCare Copenhagen ApS Company Information
- 8.2.2 BioCare Copenhagen ApS Business Overview
- 8.2.3 BioCare Copenhagen ApS Longum Sales, Value and Gross Margin (2021-2026)
- 8.2.4 BioCare Copenhagen ApS Longum Product Portfolio
- 8.2.5 BioCare Copenhagen ApS Recent Developments
- 8.3 Biofodan A/S
- 8.3.1 Biofodan A/S Company Information
- 8.3.2 Biofodan A/S Business Overview
- 8.3.3 Biofodan A/S Longum Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Biofodan A/S Longum Product Portfolio
- 8.3.5 Biofodan A/S Recent Developments
- 8.4 BioGaia AB
- 8.4.1 BioGaia AB Company Information
- 8.4.2 BioGaia AB Business Overview
- 8.4.3 BioGaia AB Longum Sales, Value and Gross Margin (2021-2026)
- 8.4.4 BioGaia AB Longum Product Portfolio
- 8.4.5 BioGaia AB Recent Developments
- 8.5 Danisco A/S
- 8.5.1 Danisco A/S Company Information
- 8.5.2 Danisco A/S Business Overview
- 8.5.3 Danisco A/S Longum Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Danisco A/S Longum Product Portfolio
- 8.5.5 Danisco A/S Recent Developments
- 8.6 Danone SA
- 8.6.1 Danone SA Company Information
- 8.6.2 Danone SA Business Overview
- 8.6.3 Danone SA Longum Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Danone SA Longum Product Portfolio
- 8.6.5 Danone SA Recent Developments
- 8.7 Deerland Enzymes Inc
- 8.7.1 Deerland Enzymes Inc Company Information
- 8.7.2 Deerland Enzymes Inc Business Overview
- 8.7.3 Deerland Enzymes Inc Longum Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Deerland Enzymes Inc Longum Product Portfolio
- 8.7.5 Deerland Enzymes Inc Recent Developments
- 8.8 Hanson Ltd
- 8.8.1 Hanson Ltd Company Information
- 8.8.2 Hanson Ltd Business Overview
- 8.8.3 Hanson Ltd Longum Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Hanson Ltd Longum Product Portfolio
- 8.8.5 Hanson Ltd Recent Developments
- 8.9 Mystic Pharmaceuticals Inc
- 8.9.1 Mystic Pharmaceuticals Inc Company Information
- 8.9.2 Mystic Pharmaceuticals Inc Business Overview
- 8.9.3 Mystic Pharmaceuticals Inc Longum Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Mystic Pharmaceuticals Inc Longum Product Portfolio
- 8.9.5 Mystic Pharmaceuticals Inc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Longum Value Chain Analysis
- 9.1.1 Longum Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Longum Sales Mode & Process
- 9.2 Longum Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Longum Distributors
- 9.2.3 Longum Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst